Archive << | < | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | > | >>
Consultation on improving imported food controls at Heathrow The Food Standards Agency today announced proposals for improving controls on imported food arriving at Heathrow Airport.
FSA welcomes EFSA opinion on semicarbazide The Food Standards Agency has today welcomed a new opinion from the European Food Safety Authority EFSA on semicarbazide in food.
EFSA launches public consultation on post-market environmental monitoring of GM Plants The European Food Safety Authority EFSA has today opened a public consultation on the Post Market Environmental Monitoring PMEM of Genetically Modified GM Plants.
EFSA consults widely on risk assessment of GM Microorganisms The European Food Safety Authority EFSA has today launched an open consultation on its guidance document for the risk assessment of Genetically Modified Microorganisms GMMs
Orange in Poland The Management Board of PTK Centertel took the strategic decision to introduce the Orange brand into the polish market.
blue connect: a new service in the Era network – the fastest wireless Internet Polska Telefonia Cyfrowa PTC , operator of the Era and Heyah networks, is launching a new service of wireless access to the Internet, as well as network and corporate applications, called blue connect.
Proxim Offers High-Capacity Bandwidth with Newest Additions to the Tsunami QuickBridge Proxim Corporation, a global leader in wireless networking equipment for Wi-Fi and broadband wireless networks, today announced two additions to its Tsunami QuickBridge.11 product line that will significantly increase spectrum capacity.
FDA Advisory Committee recommends continued availability of Serevent for treatment of asthma RESEARCH TRIANGLE PARK, N.C. — An advisory panel to the US Food and Drug Administration met today to discuss the safety of long-acting beta2-agonists.
Novartis completes tender offer for Eon Labs, Inc. and purchase of majority stake Novartis announced today that Zodnas Acquisition Corp., an indirect wholly owned subsidiary of Novartis AG, has successfully completed its tender offer for the outstanding public shares of Eon Labs, Inc.
Novartis completes acquisition of 98 of Eon Labs Novartis announced today that it has completed the acquisition of approximately 98 of US-based generic pharmaceutical company Eon Labs, Inc.
<< | < | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | > | >>
| 
